Clinical Trial Update: A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating a tetravalent live attenuated dengue vaccine in dengue-naive children completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Dengue | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-11-26